Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer

[1] Smyth EC(2017)Oesophageal cancer Nat Rev Dis Primers 3 17048-335

[2] Lagergren J(2021)Understanding the immuno-biology of oesophageal adenocarcinoma: towards improved therapeutic approaches Cancer Treat Rev 98 102219-2940

[3] Fitzgerald RC(2014)Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death Oncoimmunology 3 e28518-526

[4] Lonie JM(2020)Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations Radiat Oncol 15 254-279

[5] Barbour AP(2017)Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors Adv Anat Pathol 24 311-1093

[6] Dolcetti R(2017)IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade J Clin Invest 127 2930-397

[7] Golden EB(1994)Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 515-349

[8] Frances D(2016)Estimating the concordance probability in a survival analysis with a discrete number of risk groups Lifetime Data Anal 22 263-887

[9] Pellicciotta I(2009)ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks Bioinformatics 25 1091-457

[10] Demaria S(2017)Lipocalin-2: a master mediator of intestinal and metabolic inflammation Trends Endocrinol Metab 28 388-3827

[1] Smyth EC(2017)Oesophageal cancer Nat Rev Dis Primers 3 17048-335

[2] Lagergren J(2021)Understanding the immuno-biology of oesophageal adenocarcinoma: towards improved therapeutic approaches Cancer Treat Rev 98 102219-2940

[3] Fitzgerald RC(2014)Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death Oncoimmunology 3 e28518-526

[4] Lonie JM(2020)Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations Radiat Oncol 15 254-279

[5] Barbour AP(2017)Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors Adv Anat Pathol 24 311-1093

[6] Dolcetti R(2017)IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade J Clin Invest 127 2930-397

[7] Golden EB(1994)Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 515-349

[8] Frances D(2016)Estimating the concordance probability in a survival analysis with a discrete number of risk groups Lifetime Data Anal 22 263-887

[9] Pellicciotta I(2009)ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks Bioinformatics 25 1091-457

[10] Demaria S(2017)Lipocalin-2: a master mediator of intestinal and metabolic inflammation Trends Endocrinol Metab 28 388-3827